| Literature DB >> 27179792 |
Toji Miyagawa1,2, Ihori Ebinuma1, Yuichi Morohashi1, Yukiko Hori1, Mee Young Chang3, Haruhiko Hattori4, Tomoaki Maehara4, Satoshi Yokoshima4, Tohru Fukuyama4, Shoji Tsuji5, Takeshi Iwatsubo6, George C Prendergast3, Taisuke Tomita1.
Abstract
BIN1 is a genetic risk factor of late-onset Alzheimer disease (AD), which was identified in multiple genome-wide association studies. BIN1 is a member of the amphiphysin family of proteins, and contains N-terminal Bin-Amphiphysin-Rvs and C-terminal Src homology 3 domains. BIN1 is widely expressed in the mouse and human brains, and has been reported to function in the endocytosis and the endosomal sorting of membrane proteins. BACE1 is a type 1 transmembrane aspartyl protease expressed predominantly in neurons of the brain and responsible for the production of amyloid-β peptide (Aβ). Here we report that the depletion of BIN1 increases cellular BACE1 levels through impaired endosomal trafficking and reduces BACE1 lysosomal degradation, resulting in increased Aβ production. Our findings provide a mechanistic role of BIN1 in the pathogenesis of AD as a novel genetic regulator of BACE1 levels and Aβ production.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27179792 DOI: 10.1093/hmg/ddw146
Source DB: PubMed Journal: Hum Mol Genet ISSN: 0964-6906 Impact factor: 6.150